摘要
目的观察舒巴坦／头孢哌酮治疗慢性支气管炎革兰阴性菌（G一菌）感染的临床疗效。方法将120例慢性支气管炎合并G_菌感染的患者，随机分为舒巴坦／头孢哌酮治疗组和头孢他啶对照组，每组均60例，观察两组患者的临床疗效、细菌清除率及不良反应。结果舒巴坦／头孢哌酮治疗组60例患者，总有效率93．3％，细菌清除率90％，不良反应发生率3．3％；头孢他啶对照组60例患者，总有效率73．7％，细菌清除率73．3％，不良反应发生率6．6％。结论舒巴坦，头孢哌酮对慢性支气管炎G-菌感染的患者疗效好，不良反应少。
Objective To observe the sulbactam / cefoperazone treatment of chronic bronchitis of gram-negative bacteria （G-bacteria） infection in clinical efficacy. Methods 120 cases of chronic bronchitis and G-bacteria infected patients were randomly divided into sulbactam / cefoperazone and ceftazidime in the treatment group and control group were 60 cases, patients were observed clinical efficacy, bacterial eradication rate and adverse reactions. Results sulbactam / cefoperazone group of 60 patients t^ated, the total effective rate was 93.3%, bacterial eradication rate was 90%, 3.3% incidence of adverse reactions; ceftazidime and 60 patients in control group, the total ef- fective rate 73.7%, bacterial clearance rate was 73.3 % adverse reaction rate of 6.6%. Conclusion sulbactam / cefoperazone in chronic bronchitis patients G-infection is effective, less side effects.
